Published in J Am Coll Cardiol on April 01, 1999
Stenting for chronic total occlusion of the proximal subclavian artery. Interv Neuroradiol (2007) 0.98
A forgotten vascular disease with important clinical implications. Subclavian steal syndrome. Am J Case Rep (2013) 0.94
Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting. Vasc Health Risk Manag (2007) 0.92
Coronary-subclavian steal syndrome: percutaneous approach. Case Rep Cardiol (2013) 0.83
Bilateral subclavian steal syndrome. Case Rep Cardiol (2011) 0.75
Sudden cardiac arrest with acute myocardial infarction induced by left subclavian artery occlusion in a patient with prior coronary artery bypass surgery. Korean Circ J (2012) 0.75
The times they are a-changin'.... J Am Coll Cardiol (1999) 0.75
Endovascular Treatment of Proximal Aortic Arch Lesions through a Retrograde Approach. Interv Neurol (2015) 0.75
Percutaneous reconstruction of the innominate bifurcation using the retrograde 'kissing stents' technique. Neuroradiology (2006) 0.75
A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet (2001) 4.58
Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child (2001) 2.07
Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med (2007) 1.78
Prenatal maternal blood pressure response to stress predicts birth weight and gestational age: a preliminary study. Am J Obstet Gynecol (1996) 1.59
Human chorionic gonadotropin: its possible role in maternal lymphocyte suppression. Science (1973) 1.59
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure (1997) 1.52
A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. Structure (1997) 1.51
Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. Biochemistry (1997) 1.50
Dynamic changes in HIV-1 quasispecies from azidothymidine (AZT)-treated patients. FASEB J (1992) 1.41
The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics (1992) 1.40
Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med (1997) 1.40
Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera. J Virol (1992) 1.39
600 ps molecular dynamics reveals stable substructures and flexible hinge points in cAMP dependent protein kinase. Biopolymers (1999) 1.32
Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase. Biochemistry (1999) 1.29
Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses (1998) 1.27
Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet (1994) 1.25
Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Intern Med J (2010) 1.23
Pharmacokinetics and pharmacodynamics of ibuprofen isomers and acetaminophen in febrile children. Clin Pharmacol Ther (1992) 1.21
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine (2002) 1.20
Large linkage analysis in 100 families with autosomal recessive spinal muscular atrophy (SMA) and 11 CEPH families using 15 polymorphic loci in the region 5q11.2-q13.3. Genomics (1994) 1.18
Conserved water molecules contribute to the extensive network of interactions at the active site of protein kinase A. Proc Natl Acad Sci U S A (1998) 1.18
SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother (1997) 1.17
Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child (2002) 1.15
The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline. Antiviral Res (1991) 1.10
Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol (1999) 1.08
A new scale to assess radiographic success of secondary alveolar bone grafts. Cleft Palate Craniofac J (2002) 1.07
Primary biliary cirrhosis in mother and daughter. Br Med J (1977) 1.04
Acute effects of aerobic exercise on mood. Health Psychol (1988) 1.04
The nature and assessment of general well-being. J Psychosom Res (1983) 1.02
Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? Br J Cancer (2003) 1.00
Backbone flexibility of five sites on the catalytic subunit of cAMP-dependent protein kinase in the open and closed conformations. Biochemistry (1998) 0.99
Detection of first-order liquid/liquid phase transitions in yttrium oxide-aluminum oxide melts. Science (2008) 0.98
Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. Addiction (1999) 0.98
Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med (2000) 0.97
A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein. Cancer Res (2001) 0.97
From sequence to chromosome: the tip of the X chromosome of D. melanogaster. Science (2000) 0.96
Parental concern and distress about infant pain. Arch Dis Child Fetal Neonatal Ed (2004) 0.95
Asphalt volcanism and chemosynthetic life in the Campeche Knolls, Gulf of Mexico. Science (2004) 0.95
Enteral feeding: practice guidance. Paediatr Nurs (2000) 0.95
The need for palliative care for patients with non-cancer diseases: a review of the evidence. Int J Palliat Nurs (2001) 0.95
Towards efficient guidelines: how to monitor guideline use in primary care. Health Technol Assess (2003) 0.95
Functional malleability of the carboxyl-terminal tail in protein kinase A. J Biol Chem (1996) 0.93
Development of a panel of monochromosomal somatic cell hybrids for rapid gene mapping. Ann Hum Genet (1995) 0.93
Identification of selective inhibitors of cyclin dependent kinase 4. Bioorg Med Chem Lett (2001) 0.93
Meta-analysis on the efficacy of foot-and-mouth disease emergency vaccination. Prev Vet Med (2011) 0.92
High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population. Tissue Antigens (2006) 0.92
HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdine. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.92
Dementia care provision in rural Scotland: service users' and carers' experiences. Health Soc Care Community (2005) 0.90
Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains. Vet Microbiol (2007) 0.90
Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis. Chest (1997) 0.89
Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. Cytogenet Cell Genet (1996) 0.89
Experimental studies with foot-and-mouth disease virus, strain O, responsible for the 2001 epidemic in the United Kingdom. Vaccine (2002) 0.89
Evidence for the absence of intron H of the histidine-rich glycoprotein (HRG) gene: genetic mapping and in situ localization of HRG to chromosome 3q28-q29. Genomics (1994) 0.88
Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine. AIDS Res Hum Retroviruses (1990) 0.88
Porcine gammadelta T cells: possible roles on the innate and adaptive immune responses following virus infection. Vet Immunol Immunopathol (2006) 0.88
Complications of cholecystectomy in district general hospitals. Br J Clin Pract (1990) 0.88
Diagnosis of heart failure in elderly patients in primary care. Eur J Heart Fail (2001) 0.87
Impact of a multiple, IVF birth on post-partum mental health: a composite analysis. Hum Reprod (2007) 0.86
A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease. Antiviral Res (2012) 0.85
Weak charge-lattice coupling requires reinterpretation of stripes of charge order in La1-xCaxMnO3. Phys Rev Lett (2005) 0.85
Pharmacokinetics of phenytoin in children with acute neurotrauma. Crit Care Med (1995) 0.85
Hormone-responsive creatine kinase in normal and neoplastic mammary glands. Ann N Y Acad Sci (1986) 0.84
Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1. Antimicrob Agents Chemother (1989) 0.84
Yield drag in a two-dimensional foam flow around a circular obstacle: effect of liquid fraction. Eur Phys J E Soft Matter (2007) 0.84
Increased activation of the combination of 3'-azido-3'-deoxythymidine and 2'-deoxy-3'-thiacytidine in the presence of hydroxyurea. Antimicrob Agents Chemother (1997) 0.83
Human chorionic gonadotropin: inhibitory effect on mixed lymphocyte cultures. Gynecol Invest (1973) 0.83
The CEPH consortium linkage map of human chromosome 11. Genomics (1995) 0.83
Haematoma of rectus abdominis from the use of an exercise wheel: a report of 3 cases. Br J Surg (1974) 0.83
Comparison of extraction procedures for high-performance liquid chromatographic determination of cellular deoxynucleotides. J Chromatogr A (1994) 0.83
Human lymphocytes resistant to 6-thioguanine increase with age. Mech Ageing Dev (1982) 0.83
Immune mechanisms in leukemia: suppression of cellular immunity by starvation. J Natl Cancer Inst (1975) 0.83
Development of a Physiologically-Based Pharmacokinetic Model for Sirolimus: Predicting Bioavailability Based on Intestinal CYP3A Content. CPT Pharmacometrics Syst Pharmacol (2013) 0.83
Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC. Vet Microbiol (2004) 0.83
Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi? Circulation (1989) 0.83
Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsies. Arch Surg (1994) 0.82
Bowel rehabilitation: an alternative to long-term parenteral nutrition and intestinal transplantation for some patients with short bowel syndrome. Transplant Proc (2002) 0.82
Systems for implementing best practice for a chronic disease: management of osteoarthritis of the hip and knee. Intern Med J (2006) 0.82
High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation (1995) 0.82
Carbamazepine plasma concentration. Relationship to cognitive impairment. Arch Neurol (1987) 0.81
Improved sample preparation method for high-performance liquid chromatography of deoxyribonucleoside triphosphates from cell culture extracts. J Chromatogr (1990) 0.81
Quinazolines as cyclin dependent kinase inhibitors. Bioorg Med Chem Lett (2001) 0.81
Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments. J Vet Pharmacol Ther (2012) 0.81
Mechanisms of uptake and the fate of serum proteins and horseradish peroxidase in cultured human glioma cells. A light- and electron-immunocytochemical study. Acta Neuropathol (1980) 0.81
Prevalence of infection with HIV, hepatitis B and C viruses, in four high risk groups in Eritrea. Clin Diagn Virol (1998) 0.81
Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine. Antimicrob Agents Chemother (1996) 0.81
High-throughput synthesis of functionalized oligonucleotides. Nucleic Acids Symp Ser (1997) 0.81
HIV infection: the spectrum of symptoms and disease in male and female patients attending a London hospice. Palliat Med (1997) 0.80
Population pharmacokinetics of felbamate in children. Ther Drug Monit (1997) 0.80
SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2. Antiviral Res (1997) 0.80
Study of the histochemical changes in mucus from normal and tumour bearing mucosa in patients with colorectal cancer. Eur J Surg Oncol (1985) 0.80
How I coped emotionally with diabetes in my family. Prof Care Mother Child (1996) 0.80
Analysis of HIV-1 reverse transcriptase gene mutations in infected children treated with zidovudine. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.79
Carbamazepine age-dose ratio relationship in children. Ther Drug Monit (1991) 0.79
Report and abstracts of the Third International Workshop on Human Chromosome 2 Mapping 1994. Aarhus, Denmark, June 24-26, 1994. Cytogenet Cell Genet (1994) 0.79
SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. Antiviral Res (1993) 0.79
The effects of interferons on the activity of alpha-glycerolphosphate dehydrogenase in benign prostatic hyperplasia cells in primary culture. J Urol (1987) 0.79
Bilateral simultaneous patellar tendon rupture in a female collegiate gymnast. A case report. Am J Sports Med (1986) 0.79
Phenytoin age-dose-concentration relationship in children. Ther Drug Monit (1994) 0.78
Cell-free expression of the coxsackievirus 3C protease using the translational initiation signal of an insect virus RNA and its characterization. Virus Res (1991) 0.78
Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen. Vaccine (2011) 0.78